Research explained
Focused ultrasound for glioblastoma: what our review examines
A research summary of the Strickland team’s review of focused ultrasound, drug delivery, and immune responses in glioblastoma.
By Strickland Brain Lab ·
A way to deliver energy to the tumor
Focused ultrasound uses acoustic energy to produce controlled mechanical or thermal effects. In glioblastoma research, investigators are studying how these effects could support drug delivery and change the local immune environment.
Our team’s review, Engineering focused ultrasound for glioblastoma, was published in Brain Stimulation. Authors include Marcus Bell, Chase Walton, and Dr. Ben Strickland. It brings together preclinical studies and early clinical work rather than reporting a new treatment trial.
What the review covers
The review examines how acoustic pressure, exposure time, and duty cycle shape the biological effects of ultrasound. It discusses temporary changes in blood-brain barrier permeability, drug delivery, immune modulation, and combinations with immunotherapies. These are related research directions, but they are not interchangeable procedures.
The evidence includes laboratory models and human studies. A finding that a platform can be delivered safely or feasibly does not, by itself, establish that it improves survival.
How this fits our research
The Strickland Brain Lab studies the glioblastoma tumor microenvironment, with particular interest in immune suppression and treatment resistance. Focused ultrasound is one of the tools we investigate alongside single-cell analysis, spatial transcriptomics, and immunotherapy research.
Read the original review for the specific ultrasound approaches and evidence behind each proposed application. The publication record and DOI below identify the full paper.